IL1B and metabolic syndrome: It should be noted that proinflammatory cytokines such as TNF-α, IL6, and IL1β may promote the disruption of lipid metabolism resulting in systemic inflammation [72], and that COVID-19 itself has been associated with dyslipidemia [46], which may worsen obesity-associated dyslipidemia.